Genevant Sciences v Moderna (CFI, 23 May 2025)
| Date | 23 May 2025 |
|---|---|
| Court | CFI |
| Division | The Hague (NL) Local Division |
| Type of action | Preliminary objection |
| Registry reference | App_19773/2025 · ORD_21852/2025 |
| Parties | Moderna Italy S.R.L., Moderna France SASU, Moderna Germany GmbH, Moderna Poland SP. Z.O.O., Moderna Netherlands B.V., Moderna Denmark ApS, … |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By joint order of 23 May 2025 in the joined infringement actions UPC_CFI_191/2025 (EP 2 279 254) and UPC_CFI_192/2025 (EP 4 241 767) brought by Genevant Sciences and Arbutus Biopharma against fifteen Moderna group companies, the judge rapporteur of The Hague Local Division largely dismissed the preliminary objections. Those of Moderna Belgium and Moderna Germany, and of Moderna Poland in case 192, were late, the long-arm jurisdiction issue was left to the main proceedings.
Question
Were the objections raised within one month, does the UPC have jurisdiction over the Spanish, Polish and Norwegian companies, is The Hague division competent, and was the opt-out of EP 2 279 254 validly made and withdrawn?
Decision
The Rule 19.1 period runs from service: objections lodged on 24 April 2025 were late for the companies served first, which are deemed to accept jurisdiction (Rule 19.7) (paragraphs 11 to 13). The UPC, as a common court, applies Arts 7(2) and 8(1) of Regulation No 1215/2012 through Art. 71b: alleged joint infringement with Moderna Netherlands is enough, whether infringement actually occurred being a matter for the merits (paragraphs 15 to 18). Membership of the same group with related activities establishes the « commercial relationship » under Art. 33(1)(b) (paragraph 19). Arbutus, successor to Protiva by merger on 1 January 2018, was entitled to make and withdraw the opt-out. The Rule 8.5(c) presumption was rebutted (paragraphs 18 and 19, case 191).
Key points for practice
- The time limit for a preliminary objection runs for each defendant from its own service. A late joint filing costs the companies served first their objection.
- Membership of the same group is enough to establish the commercial relationship under Art. 33(1)(b).
Provisions applied
- Agreement on a Unified Patent Court
- Arts 31, 32(1)(a), 33(1)(a) and (b) and 63
- Rules of Procedure
- Rules 8.5(c), 19.1 and 19.7
- Regulation (EU) No 1215/2012
- Arts 7(2), 8(1), 71a and 71b
- Other instruments
- revised Lugano Convention, Arts 5(3) and 7(1)
- Case law cited
- Court of Appeal, 3 September 2024 (UPC_CoA_188/2024), Munich Local Division, 29 September 2023 (UPC_CFI_15/2023), Paris Local Division, 11 April 2024 (UPC_CFI_495/2023)
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Local and central divisions (UPC).
Dhenne Avocats blog: The Transitional Period and the UPC: Coordinating Two Judicial Orders.
Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction, Valeo v. Bosch and the Redistribution of Cases Within the UPC (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantModerna Netherlands B.V.5 decisions in the corpusFollow this party
- claimantModerna Poland SP. Z.O.O2 decisions in the corpusFollow this party
- claimantModerna France SASU4 decisions in the corpusFollow this party
- claimantModerna Germany GmbH3 decisions in the corpusFollow this party
- claimantModerna Italy S.R.L3 decisions in the corpusFollow this party
- claimantModerna Denmark ApS2 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Preliminary objection
- Outcome (Dhenne Avocats summary)
- Les exceptions préliminaires de Moderna sont rejetées, sauf irrecevabilité pour tardiveté de certaines d'entre elles. La compétence internationale et locale est retenue, l'opt-out est jugé valablement formé et retiré, et la question long-arm est renvoyée au fond.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 279 254mentioned in: Dhenne Avocats analysis Follow this patentEP 4 241 767mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- AYLO Premium v DISH Technologies (CoA, 3 September 2024) cited in this record
- SVF Holdco v ICPillar (CFI, 11 April 2024) cited in this record
- Edwards Lifesciences v Meril (CFI, 29 September 2023) cited in this record
- Arbutus Biopharma v Moderna Biotech UK (CFI, 23 May 2025) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 279 254Novel lipid formulations for nucleic acid delivery recorded proprietor: Arbutus Biopharma Corp | Mentioned in the analysis (role not qualified) Also mentioned in 7 other decision(s): Genevant Sciences v Moderna (CFI, UPC_CFI_191/2025, 25 August 2026) · Genevant Sciences v Moderna (CFI, 18 August 2025) · Genevant Sciences v Moderna (CFI, 13 August 2025) · Genevant Sciences v Moderna (CFI, 4 August 2025) · Genevant Sciences v Moderna (CFI, 12 June 2025) · Moderna v Genevant Sciences (CFI, 4 June 2025) · Genevant Sciences v Moderna (CFI, 17 April 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
EP 4 241 767 | Mentioned in the analysis (role not qualified) Also mentioned in 5 other decision(s): Genevant Sciences v Moderna (CFI, UPC_CFI_192/2025, 25 August 2026) · Genevant Sciences v Moderna (CFI, 18 August 2025) · Genevant Sciences v Moderna (CFI, 12 June 2025) · Moderna v Genevant Sciences (CFI, 4 June 2025) · Genevant Sciences v Moderna (CFI, 17 April 2025) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.